12-116277075-G-T
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 2P and 7B. PM2BP4_StrongBP6_ModerateBP7
The NM_015335.5(MED13L):c.57C>A(p.Ser19Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000066 in 151,552 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 30)
Exomes 𝑓: 0.0000028 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
MED13L
NM_015335.5 synonymous
NM_015335.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.44
Publications
0 publications found
Genes affected
MED13L (HGNC:22962): (mediator complex subunit 13L) The protein encoded by this gene is a subunit of the Mediator complex, a large complex of proteins that functions as a transcriptional coactivator for most RNA polymerase II-transcribed genes. The encoded protein is involved in early development of the heart and brain. Defects in this gene are a cause of transposition of the great arteries, dextro-looped (DTGA).[provided by RefSeq, Jul 2010]
MED13L Gene-Disease associations (from GenCC):
- cardiac anomalies - developmental delay - facial dysmorphism syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Illumina, Labcorp Genetics (formerly Invitae), G2P
- syndromic intellectual disabilityInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- congenital heart diseaseInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 12-116277075-G-T is Benign according to our data. Variant chr12-116277075-G-T is described in ClinVar as Likely_benign. ClinVar VariationId is 415974.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=3.44 with no splicing effect.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MED13L | NM_015335.5 | c.57C>A | p.Ser19Ser | synonymous_variant | Exon 1 of 31 | ENST00000281928.9 | NP_056150.1 | |
| MED13L | XM_017019090.2 | c.57C>A | p.Ser19Ser | synonymous_variant | Exon 1 of 31 | XP_016874579.1 | ||
| MED13L | XM_047428608.1 | c.-108C>A | 5_prime_UTR_variant | Exon 1 of 30 | XP_047284564.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000660 AC: 1AN: 151552Hom.: 0 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
1
AN:
151552
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000141 AC: 3AN: 213250 AF XY: 0.0000172 show subpopulations
GnomAD2 exomes
AF:
AC:
3
AN:
213250
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000278 AC: 4AN: 1439478Hom.: 0 Cov.: 34 AF XY: 0.00000140 AC XY: 1AN XY: 713814 show subpopulations
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
4
AN:
1439478
Hom.:
Cov.:
34
AF XY:
AC XY:
1
AN XY:
713814
show subpopulations
African (AFR)
AF:
AC:
0
AN:
33192
American (AMR)
AF:
AC:
0
AN:
42372
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25616
East Asian (EAS)
AF:
AC:
0
AN:
38766
South Asian (SAS)
AF:
AC:
0
AN:
82966
European-Finnish (FIN)
AF:
AC:
0
AN:
49886
Middle Eastern (MID)
AF:
AC:
0
AN:
5148
European-Non Finnish (NFE)
AF:
AC:
4
AN:
1102038
Other (OTH)
AF:
AC:
0
AN:
59494
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00000660 AC: 1AN: 151552Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 74016 show subpopulations
GnomAD4 genome
AF:
AC:
1
AN:
151552
Hom.:
Cov.:
30
AF XY:
AC XY:
0
AN XY:
74016
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41312
American (AMR)
AF:
AC:
0
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5104
South Asian (SAS)
AF:
AC:
0
AN:
4806
European-Finnish (FIN)
AF:
AC:
0
AN:
10464
Middle Eastern (MID)
AF:
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
AC:
1
AN:
67830
Other (OTH)
AF:
AC:
0
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Transposition of the great arteries, dextro-looped Benign:1
Jul 02, 2016
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.